Cite

HARVARD Citation

    Hasenfuß, G. et al. (2016). A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial. Lancet. 387 (10025), pp. 1298-1304. [Online]. 
  
Back to record